2008
DOI: 10.1002/msc.141
|View full text |Cite
|
Sign up to set email alerts
|

Providing patients with information about disease‐modifying anti‐rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction

Abstract: Our pilot study demonstrated the feasibility of providing counselling on DMARDs to groups of patients with important time savings for specialist nurses and while maintaining high levels of patient satisfaction. There was a trend for better outcomes in terms of adherence and drug continuation rates for patients counselled in groups, indicating potential benefits from group interactions. However, these findings need to be investigated further in a larger, fully powered trial.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
41
0
2

Year Published

2009
2009
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 36 publications
(43 citation statements)
references
References 16 publications
0
41
0
2
Order By: Relevance
“…We did not include here a pilot RCT of group versus individual counselling for RA34 and a pilot RCT of internet-based self-management with telephone support for JIA 44. Quality scores varied from 9 to 28 out of a maximum possible score of 32 (mean=18.6; median=18.5).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We did not include here a pilot RCT of group versus individual counselling for RA34 and a pilot RCT of internet-based self-management with telephone support for JIA 44. Quality scores varied from 9 to 28 out of a maximum possible score of 32 (mean=18.6; median=18.5).…”
Section: Resultsmentioning
confidence: 99%
“…Adherence measures varied across studies from questionnaires,26 28–30 32 37–39 41–44 47 pill counts20 34 and refill patterns 25 28 34–36 38. There was further variation within measures, for example questionnaires included validated instruments (Morisky Scale,32 37 compliance questionnaire rheumatology (CQR)29 38) and researcher developed questions 26 27 30 39 41–43 47.…”
Section: Discussionmentioning
confidence: 99%
“…[30] The difficulty of incorporating a new medication regimen into patient's lives may be reduced if they are fully understood the reasons behind each drug, and how the drug is expected to improve their health outcomes. [35][36][37][38] In the current study; patient related dimensions where it included two subcategories: physical factors such as impaired mobility or dexterity and visual impaired respectively; in psychological /behavioral factors such as fear of possible adverse effects, fear of dependence, psychosocial stress, anxiety and anger and feeling stigmatized by the disease were the most consistently notified factors affecting on medication adherence among patients with rheumatic disorders. Therefore, it is of major importance for healthcare providers to consider the psychosocial variables that affect the patient's adherence when prescribing medication.…”
Section: Discussionmentioning
confidence: 95%
“…One study estimated that only 64% of more than 80% of 1668 patients with RA were adherent to MTX therapy 17 . Although it seems intuitive, there has been little research on whether patient education could alter a patient's belief in the usefulness of taking treatment and help find a balance between understanding potential risks and benefits 18 . There are likely to be other factors associated with a patient's beliefs about medications and past illness experiences that may be more important in determining longterm treatment outcomes.…”
Section: Recommendationmentioning
confidence: 99%